首页> 外文期刊>Journal of population therapeutics and clinical pharmacology >REDUCED OUT-OF-POCKET COSTS AND MEDICATION ADHERENCE ? A POPULATION-BASED STUDY
【24h】

REDUCED OUT-OF-POCKET COSTS AND MEDICATION ADHERENCE ? A POPULATION-BASED STUDY

机译:减少了袋外成本和药物依从性?基于人口的研究

获取原文
           

摘要

Background In 2007, a drug benefit plan for seniors (SDP) was launched in Saskatchewan, Canada. SDP capped out- of-pocket costs at $15 per prescription for individuals aged 65 and older. Objectives To quantify the impact of the SDP on chronic medication adherence. Methods A retrospective cohort study was conducted for participants aged 65 or older who were eligible to the SPD, controlled by a younger group aged 40 to 64 who were ineligible. Adherence was measured over 365 days using medication possession ratio (MPR). MPRs were compared between age groups, and between pre- and post SDP-launch periods. The odds ratio of optimal adherence (i.e., MPR≥80%) was estimated using logistic regression models with generalized estimating equations (GEE). Results Between 2005 and 2009, 353,568 adherence observations were observed from 188,109 unique patients. Comparing the post-SDP period vs before, the increase in the odds of optimal medication adherence was significant (OR = 1.08, 95% CI: 1.04 to 1.11) and was stronger after excluding patients already receiving medication benefits from other government programs (OR = 1.21, 95% CI: 1.16 to 1.26). The SDP was associated with improved adherence among the subgroup of prevalent medication users (OR = 1.08, 95% CI: 1.04 to 1.12), but not incident users (OR = 1.05, 95% CI: 0.98 to 1.13).ConclusionReducing out-of-pocket medication costs for seniors was associated with small improvements in medica-tion adherence across the population.
机译:背景技术2007年,加拿大萨斯喀彻温省启动了老年人药物福利计划(SDP)。对于65岁及65岁以上的个人,SDP最高支付每笔处方15美元的费用。目的量化SDP对慢性药物依从性的影响。方法对年龄在65岁以上且符合SPD资格的参与者进行回顾性队列研究,该参与者由40岁至64岁的不合格年轻人组成。使用药物占有率(MPR)在365天内测量粘附性。比较了各个年龄段之间以及SDP推出前后的MPR。使用具有广义估计方程(GEE)的逻辑回归模型估计最佳依从性的比值比(即MPR≥80%)。结果2005年至2009年,从188,109名独特患者中观察到353,568例依从性观察。与SDP后时期相比,与之前相比,最佳药物依从性的几率显着增加(OR = 1.08,95%CI:1.04至1.11),并且在排除已经从其他政府计划中获得药物收益的患者后,其增长更为明显(OR = 1.21,95%CI:1.16至1.26)。 SDP与流行药物使用者亚组的依从性改善相关(OR = 1.08,95%CI:1.04至1.12),而与非偶然事件使用者(OR = 1.05,95%CI:0.98至1.13)没有关系。老年人的零用钱成本与整个人群对药物依从性的小改善有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号